• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcarePharmaceuticalscbdMD
    Picture of cbdMD logo

    YCBD — cbdMD News Story

    $0.370.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapValue Trap
    • Market Cap
      $4.19m
    • Enterprise Value
      $2.08m
    • Revenue
      $19.19m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • Discussion
    • YCBD Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    Discussion
    YCBD Dividends
    All News

    AMEX RESUMED CBDMD INC

    Picture of cbdMD logocbdMD
    03/12/2019 16:15
    AMEX RESUMED CBDMD INC  YCBD_pa.A
    

    Recent news on cbdMD

    See all news
    • Brief: CbdMD Reports 19% Year-Over-Year And 12% Sequential Revenue Growth

      14/05/2026 22:04
    • Brief: cbdMD Announces Strategic Acquisition of Bluebird Botanicals

      14/01/2026 14:29
    • Brief: Cbdmd Reports Preliminary Unaudited Fourth Quarter Results

      21/11/2025 14:25
    • Brief: CbdMD Inc - Effective Sep 30, Enters Securities Purchase Agreements With Four Investors - SEC Filing

      06/10/2025 23:37
    • Brief: CbdMD Inc - Reduces Principal On Senior Secured Convertible Notes To $56,000

      10/01/2025 11:14

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.